Glycogen synthase kinase 3 (GSK3) was initially described as a key enzyme involved in glycogen metabolism, but is now known to regulate a diverse array of cell functions. The study of the ...

BIO CEO & Investor Conference Format: "IPO Class of 2024 Panel" and one-on-one meetings Date: February 10, 2025 Location: New York, NY Registered conference attendees may schedule one-on-one meetings ...

Methods: Glycogen content and activity of muscle enzymes with regulatory functions in glycogen synthesis were examined. Results: Testosterone treatment increased glycogen content of extensor digitorum ...

Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent and tissue-targeted medicines, today ...

Philadelphia-based Aro Biotherapeutics’sABX-1100 is designed to deliver a glycogen synthase 1 (GYS1) specific short-interfering RNA (siRNA) therapeutic payload directly to muscle tissue.